New Jersey’s pharmaceutical and biotech industries have changed in recent years, but the sector remains strong and the state continues to attract new businesses.
August 15, 2019Developer of cannibanoid-based skin-disease treatments raises $40M
August 14, 2019Carisma Therapeutics raised nearly $60M in Series A funding. Now what?
August 13, 2019Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.
August 12, 2019NextUp: The Company Using Tech to Improve Outcomes for Mental Health Patients
August 9, 2019